Literature DB >> 17666742

Sequence-specific primed PCR (PCR-SSP) typing of HLA Class I and Class II alleles.

Klara Dalva1, Meral Beksac.   

Abstract

For donor selection in hematopoetic stem cell transplantation, two-digit sequencespecific oligonucleotide (SSO) typing may be sufficient in the related sibling transplant setting. However, SSO typing is not sensitive enough to differentiate between the alleles that share the same cis-trans linkeage sequence casettes. In unrelated donor selection, PCR using sequence-specific primers, a flexible and widely used method known to cause less ambiguious results, may be preferable. However, this technique is limited by the number of the samples that can be processed at one time and also by the number of the primer mixes that can be utilized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666742     DOI: 10.1007/978-1-59745-223-6_4

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  3 in total

1.  Multiple sclerosis and amyotrophic lateral sclerosis: a human leukocyte antigen challenge.

Authors:  Vincenzo Dattola; Fausto Famà; Margherita Russo; Rocco Salvatore Calabrò; Anna Lisa Logiudice; Maria Grazia Grasso; Francesco Patti; Maria Buccafusca
Journal:  Neurol Sci       Date:  2017-04-18       Impact factor: 3.307

2.  Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.

Authors:  Lorenzo Beretta; Blanca Rueda; Maurizio Marchini; Alessandro Santaniello; Carmen P Simeón; Vicente Fonollosa; Monica Caronni; Raquel Rios-Fernandez; Patricia Carreira; Luis Rodriguez-Rodriguez; Antonia Moreno; Miguel A López-Nevot; Ana Escalera; Maria F González-Escribano; Javier Martin; Raffaella Scorza
Journal:  Rheumatology (Oxford)       Date:  2011-11-15       Impact factor: 7.580

Review 3.  A proposal for clinical genetics (genetics in medicine) education for medical technologists and other health professionals in Japan.

Authors:  Hidetsugu Kohzaki
Journal:  Front Public Health       Date:  2014-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.